Branches of biology

Navidea Biopharmaceuticals to Host Second Quarter 2021 Earnings Conference Call and Business Update

Retrieved on: 
Wednesday, August 4, 2021
Biotechnology, General Health, Other Health, Health, Pharmaceutical, Branches of biology, Life sciences, Biology, Biotechnology, Cell biology, Mannose receptor, Biopharmaceutical, Macrophage

In addition, the recorded conference call can be replayed and will be available for 90 days following the call on Navideas website.

Key Points: 
  • In addition, the recorded conference call can be replayed and will be available for 90 days following the call on Navideas website.
  • Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics.
  • Navideas Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages.
  • The Manocept platform serves as the molecular backbone of Tc99m tilmanocept, the first product developed and commercialized by Navidea based on the platform.

Gamida Cell Announces the Date of Its Second Quarter 2021 Financial Results and Webcast

Retrieved on: 
Wednesday, August 4, 2021
Biotechnology, Health, Stem Cells, Pharmaceutical, Oncology, Branches of biology, Biology, Immune system, Lymphocytes, Medical specialties, Biotechnology, Natural killer cell, Stem cells, Leukemia, Chimeric antigen receptor T cell

ET to review its second quarter 2021 financial results and provide an update on the company.

Key Points: 
  • ET to review its second quarter 2021 financial results and provide an update on the company.
  • Gamida Cell will also provide an update on its pipeline of NAM-enabled natural killer (NK) cell therapies, including GDA-201 and genetically-modified NK cell constructs.
  • The webcast will be available on the Investors & Media section of the Gamida Cell website at www.gamida-cell.com .
  • Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases.

Green Scientific Labs Announces Key Addition To Its Executive Team

Retrieved on: 
Wednesday, August 4, 2021
Herbs, Entheogens, Euphoriants, Medicinal plants, Plants, Hemp, Rollout, Cannabis, Branches of biology, Human behavior

DAVIE, Fla., Aug. 4, 2021 /PRNewswire-PRWeb/ --Green Scientific Labs, a leading cannabis and hemp testing laboratory, recently announced the addition of Scott Moore to the Business Development Team.

Key Points: 
  • DAVIE, Fla., Aug. 4, 2021 /PRNewswire-PRWeb/ --Green Scientific Labs, a leading cannabis and hemp testing laboratory, recently announced the addition of Scott Moore to the Business Development Team.
  • Moore will play a part in its nationwide rollout and ongoing commitment to providing industry-leading support and service to its existing and future customer base.
  • Paul Crage, Co-Founder and Chief Executive Officer, stated, "We are very fortunate to add someone with Scott's experience to the team.
  • Green Scientific Labs continues its nationwide rollout with the opening of a full-service laboratory in Phoenix, Ariz., with future locations soon to follow in the midwest and northeast regions of the country.

Potato-Based Milk Enters the Booming Plant-Based Milk Market With a Bang

Retrieved on: 
Wednesday, August 4, 2021
Plants, Plant morphology, Cuisine of Northern Ireland, Irish cuisine, Potato, Solanum, Tubers, Branches of biology, Forward-looking statement

However, many of these crops, like oats, can be resource-intensive and tricky to harvest, which is why Swedish companyDug is introducing a potato-based milk to the booming plant-based milk market.

Key Points: 
  • However, many of these crops, like oats, can be resource-intensive and tricky to harvest, which is why Swedish companyDug is introducing a potato-based milk to the booming plant-based milk market.
  • This $1 billion dollar category in the US brings a vastly larger customer base into the company's sights.
  • To bolster its global medical market, clinical, and regulatory affairs, Else Nutrition announced strategic additions to its team.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Potato-Based Milk Enters the Booming Plant-Based Milk Market With a Bang

Retrieved on: 
Wednesday, August 4, 2021
Plants, Plant morphology, Cuisine of Northern Ireland, Irish cuisine, Potato, Solanum, Tubers, Branches of biology, Forward-looking statement

NEW YORK, Aug. 4, 2021 /PRNewswire/ -- Plant-based milk has taken the food industry by storm, with products popping up on shelves made from oats, cashews, almonds, coconuts, hazelnuts, walnuts, barley, rice - the list goes on. However, many of these crops, like oats, can be resource-intensive and tricky to harvest, which is why Swedish company Dug is introducing a potato-based milk to the booming plant-based milk market. At the same time, companies within the plant-based food space are continuing to ramp up their plant-based offerings in an effort to gain a larger share of the $7 billion market. Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF) is one of the most innovative companies developing plant-based nutrition for babies and toddlers via its Else Nutrition lines of formula and other products. Companies like KKR & Co. Inc. (NYSE:KKR) and Yum! Brands (NYSE:YUM) collaborated to bring the innovating Violife vegan cheese and Pizza Hut stuffed crust dish to Pizza Hut. Oatly (NASDAQ:OTLY) and Tyson Foods (NYSE:TSN) continue to develop plant-based alternatives that consumers seem to love.

Key Points: 
  • However, many of these crops, like oats, can be resource-intensive and tricky to harvest, which is why Swedish company Dug is introducing a potato-based milk to the booming plant-based milk market.
  • This $1 billion dollar category in the US brings a vastly larger customer base into the company's sights.
  • To bolster its global medical market, clinical, and regulatory affairs, Else Nutrition announced strategic additions to its team.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's

Retrieved on: 
Wednesday, August 4, 2021
Branches of biology, Biology, Psychiatric diagnosis, Neurodegenerative disorders, Neurodegeneration, Neuroscience, Senescence, Alzheimer's disease, Parkinson's disease

The composition of matter patent secures exclusivity for a new group of iron chaperones designed to redistribute the excess iron implicated in many neurodegenerative diseases, including Alzheimer's and Parkinson's.

Key Points: 
  • The composition of matter patent secures exclusivity for a new group of iron chaperones designed to redistribute the excess iron implicated in many neurodegenerative diseases, including Alzheimer's and Parkinson's.
  • The patent, entitled "Compounds for and Methods of Treating Diseases", covers more than80 novel compounds and underwent prioritized examination by the USPTO.Together with the recent grant of Alterity's US patent No.
  • This position was further exemplified by the absence of any novelty or inventiveness objections during the course of prosecution.
  • Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people livingwith neurodegenerative diseases.

Stories of the Pandemic, mRNA Vaccines, Atoms, Planet Earth, and the Big Bang Come Alive for Children in Two 2021 Award-Winning Illustrated Children's STEM Books

Retrieved on: 
Wednesday, August 4, 2021
Branches of biology, Life sciences, Biology, RNA, Biotechnology, Nucleic acids, Molecular biology, Virus, DNA, RNA vaccine, Introduction to viruses

They learn in simple terms about the genetic code, DNA, cell biology, viruses, bacteria, vaccines, RNA, and messenger RNA (mRNA).

Key Points: 
  • They learn in simple terms about the genetic code, DNA, cell biology, viruses, bacteria, vaccines, RNA, and messenger RNA (mRNA).
  • Our COVID-19-Coronavirus LEARNING PAGEincludes eight illustrated short stories, video links, lesson plans, and questions.
  • LEARNING PAGES for Atoms, Planet Earth, and The Universe are also available on the Educators tab of TheStardustMystery.com web site.
  • "There are so many wonderful and exciting stories in science to tell," said Dr. Peter Solomon, CEO of TheBeamer LLC.

Generate Life Sciences to Provide DNA Ancestry Information in California Cryobank's Online Catalog

Retrieved on: 
Wednesday, August 4, 2021
Reproduction, Fertility medicine, Sperm donation, Semen, Branches of biology, Human reproduction, Giving, Cryobiology, Sperm bank, California Cryobank, Sperm, Donor Sibling Registry

LOS ANGELES, Aug. 4, 2021 /PRNewswire/ -- Generate Life Sciences today announced that California Cryobank, its industry-leading donor sperm bank, is now able to provide DNA-based donor ancestry information directly to prospective parents and donor-conceived children on Cryobank.com .

Key Points: 
  • LOS ANGELES, Aug. 4, 2021 /PRNewswire/ -- Generate Life Sciences today announced that California Cryobank, its industry-leading donor sperm bank, is now able to provide DNA-based donor ancestry information directly to prospective parents and donor-conceived children on Cryobank.com .
  • "Accessing direct-to-consumer ancestry services means sharing your most personal data with an online database, which may not appeal to many sperm donor-conceived families.
  • The DNA ancestry information for California Cryobank donors will be displayed as percentages on a world map divided into 26 distinct regions and ancestral groups.
  • For more information on Generate Life Sciences' DNA ancestry service, please visit cryobank.com/services/dna-ancestry .

World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors

Retrieved on: 
Wednesday, August 4, 2021
Medicine, Clinical medicine, Branches of biology, Cancer, Melanoma, Targeted therapy, LinkedIn, Biomarker

Ph.D.), a world-renowned expert on Melanoma has joined the company's Board of Advisors.

Key Points: 
  • Ph.D.), a world-renowned expert on Melanoma has joined the company's Board of Advisors.
  • Dr. Gil Feiler, Director and Advisory Board Chair commented: "It is an exceptionally great honor to have Prof. Robert join our Advisory Board.
  • Her more recent work is focused on identification of new biomarkers for immunotherapy and targeted therapies of patients with melanoma.
  • For the latest updates on Cannabics Pharmaceuticals follow the Company on Twitter @Cannabics, Facebook @CannabicsPharmaceuticals, LinkedIn, and on Instagram @Cannabics_Pharmaceuticals.

Kintara Therapeutics to Present at the BTIG Virtual Biotechnology Conference on August 9, 2021

Retrieved on: 
Wednesday, August 4, 2021
Cancer, Branches of biology, Causes of death, GBM, Glioblastoma, Glioblast, Breast cancer

Mr. Zarrabian will deliver his corporate presentation on Monday, August 9, 2021 at 2:00 p.m.

Key Points: 
  • Mr. Zarrabian will deliver his corporate presentation on Monday, August 9, 2021 at 2:00 p.m.
  • The live webcast will be available on the BTIG conference website at the time of the event, after which it will be available through BTIG research access.
  • Investors can also request a one-on-one meeting with Mr. Zarrabian to be arranged following the conclusion of the conference.Please contact a BTIG conference representative.
  • Kintara is currently developing two Phase 3-ready therapeutics, VAL-083 for glioblastoma multiforme (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC).